Guidelines for the management of adult myelodysplastic syndromes

被引:17
|
作者
Killick, Sally B. [1 ]
Ingram, Wendy [2 ]
Culligan, Dominic [3 ]
Enright, Helen [4 ]
Kell, Jonathan [2 ]
Payne, Elspeth M. [5 ]
Krishnamurthy, Pramila [6 ]
Kulasekararaj, Austin [6 ]
Raghavan, Manoj [7 ]
Stanworth, Simon J. [8 ,9 ]
Green, Simone [10 ]
Mufti, Ghulam [6 ]
Quek, Lynn [6 ]
Cargo, Catherine [11 ]
Jones, Gail L. [12 ]
Mills, Juliet [13 ,14 ]
Sternberg, Alex [15 ]
Wiseman, Daniel H. [16 ]
Bowen, David [11 ]
机构
[1] Univ Hosp Dorset NHS Fdn Trust, Royal Bournemouth Hosp, Bournemouth, Dorset, England
[2] Univ Hosp Wales, Cardiff, Wales
[3] Aberdeen Royal Infirm, Aberdeen, Scotland
[4] Trinity Coll Dublin, Tallaght Univ Hosp, Med Sch, Dublin, Ireland
[5] UCL, Canc Inst, London, England
[6] Kings Coll Hosp NHS Fdn Trust, London, England
[7] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England
[8] Univ Oxford, Oxford Univ Hosp NHS Trust, Oxford, England
[9] NHS Blood & Transplant, Oxford, England
[10] Hull & East Yorkshire Hosp NHS Trust, Kingston Upon Hull, N Humberside, England
[11] Leeds Teaching Hosp, St Jamess Inst Oncol, Leeds, W Yorkshire, England
[12] Newcastle Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England
[13] Worcestershire Acute Hosp NHS Trust, Worcester, England
[14] Birmingham NHS Fdn Trust, Worcester, England
[15] Great Western Hosp NHS Fdn Trust, Swindon, Wilts, England
[16] Christie NHS Fdn Trust, Manchester, Lancs, England
关键词
myelodysplastic syndromes; MDS; guideline; management; STEM-CELL TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; TRANSFUSION-DEPENDENT PATIENTS; CONVENTIONAL CARE REGIMENS; PROGNOSTIC SCORING SYSTEM; COLONY-STIMULATING FACTOR; IRON CHELATION-THERAPY; RANDOMIZED PHASE-III; LABILE PLASMA IRON; RISK MDS PATIENTS;
D O I
10.1111/bjh.17612
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:267 / 281
页数:15
相关论文
共 50 条
  • [21] The Management of Low-Risk Myelodysplastic Syndromes-Current Standards and Recent Advances
    Randall, Michael P.
    DeZern, Amy E.
    CANCER JOURNAL, 2023, 29 (03) : 152 - 159
  • [22] Standard Therapy for Patients With Myelodysplastic Syndromes
    Al-Ameri, Ali
    Cherry, Mohamad
    Garcia-Manero, Guillermo
    Quintas-Cardama, Alfonso
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (04) : 303 - 313
  • [23] Supportive Care for Patients With Myelodysplastic Syndromes
    Stempel, Jessica M.
    Podoltsev, Nikolai A.
    Dosani, Talib
    CANCER JOURNAL, 2023, 29 (03) : 168 - 178
  • [24] Myelodysplastic syndromes: a review of therapeutic progress over the past 10 years
    Feld, Jonathan
    Belasen, Abigail
    Navada, Shyamala C.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (06) : 465 - 482
  • [25] Myelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and management
    Montalban-Bravo, Guillermo
    Garcia-Manero, Guillermo
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (01) : 129 - 147
  • [26] Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management
    Garcia-Manero, Guillermo
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (01) : 97 - 108
  • [27] Myelodysplastic syndromes: 2023 update on diagnosis, risk-stratification, and management
    Garcia-Manero, Guillermo
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (08) : 1307 - 1325
  • [28] Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management
    Garcia-Manero, Guillermo
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (07) : 692 - 701
  • [29] Current therapy of myelodysplastic syndromes
    Zeidan, Amer M.
    Linhares, Yuliya
    Gore, Steven D.
    BLOOD REVIEWS, 2013, 27 (05) : 243 - 259
  • [30] Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes
    Wang, Chen
    Sallman, David. A. A.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (05) : 387 - 408